Jpmorgan Chase & CO Emergent Bio Solutions Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EBS
# of Institutions
147Shares Held
30.4MCall Options Held
137KPut Options Held
706K-
Black Rock Inc. New York, NY3.84MShares$33.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.67MShares$32.2 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA3.17MShares$27.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.24MShares$10.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny946KShares$8.3 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $437M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...